Product Specifications: Lyophilized Powder (>99% purity) in 3ml vial. *Requires Reconstitution ** Available for bulk custom order with 57 Cap/Crimp colors to choose from.
Application: Research peptide evaluated in skeletal health, strength building, anti-aging, metabolism, tissue repair
Chemial Formula: CJC-1295: C152H252N44O42, Ipamorelin: C38H49N9O5
CAS Number: CJC-1295: 863288-34-0, Ipamorelin: 170851-70-4
Molecular Weight: ~3367.9 g/mol
Concentration: ≥99%
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to elevate plasma growth hormone (GH) levels 1. Ipamorelin acts as a selective growth hormone secretagogue and ghrelin mimetic, stimulating the pituitary gland to release growth hormone 2. When combined, these peptides create a synergistic effect that enhances natural growth hormone release while producing minimal increases in cortisol and prolactin levels compared to other growth hormone stimulants.
Primary Research Applications
1. Muscle Development and Performance
- Muscle mass and strength development
- Athletic performance enhancement
- Overall physical performance
2. Metabolic Effects and Body Composition
- Weight loss promotion
- Fat reduction
- Metabolic regulation
- Enhanced body composition through decreased body fat while maintaining lean muscle mass
3. Tissue Repair and Recovery
- Accelerated healing from injuries
- Musculoskeletal tissue repair
- Enhanced recovery processes
4. Age-Related Applications
- Improved skin elasticity
- Enhanced cognitive function
- Overall vitality improvement
- General age-related decline prevention
5. Skeletal Health
- Bone density improvement
- Skeletal integrity enhancement
- Overall bone health optimization
References:
Gobburu, J. V., Agersø, H., Jusko, W. J., & Ynddal, L. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical Research, 16(9), 1412-1416.
Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism, 91(3), 799-805. https://doi.org/10.1210/jc.2005-2113
Alba, M., Fintini, D., Bowers, C. Y., Parlow, A. F., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism, 291(6), E1290-E1294. https://doi.org/10.1152/ajpendo.00201.2006
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Researchers should handle all peptides with care and adhere to strict safety guidelines during experiments. Only qualified professionals with appropriate expertise should manage and handle this product. The distributor, manufacturer, and seller of this product are not responsible for misuse or any resulting consequences. By accessing this product, you consent to comply with these terms and conditions.
